KalshiVerfügbarkeit prüfenKYC erforderlich2% GebührVerifizierte AuflösungsdatenGrob kalibriertAktuelle implizite Wahrscheinlichkeitbefore April 2027 67%Führend unter 6 Optionen
Marktqualitat
37 / 100
Niedrige Qualität24h-Volumen
0 €
Liquidität
1981,9 €
Niedrige LiquiditätGeld / Brief
3.0% / 10.0%
Spread
7.0 pt
Breiter SpreadMarktdaten
Aktualisiert vor 21 Minuten
24. März 26, 14:001. Sept. 26, 14:00
Trends
0%
Nur virtuelles Guthaben – kein echtes GeldKeine Finanzberatung
Gewähltes Ergebnis
before September10%
Volumentrend
$124. Juli13T Daten25. Juli
Verwandte Märkte
Testosterone unscheduled/rescheduled more permissively in US by end of 2028?
511,1 €Ja: 17.8%MANIFOLD MARKETS
MANIFOLD MARKETSWill there be a cure for schizophrenia before 2032?
439,4 €Ja: 11.8%MANIFOLD MARKETS
MANIFOLD MARKETSWill artificial blood be used to treat a patient by the end of 2026?
439,4 €Ja: 9.7%MANIFOLD MARKETS
MANIFOLD MARKETS
Will there be a year without polio before 2030?
15,4 €Ja: 6%KALSHI
KALSHI
Hantavirus vaccine in 2026?
0,9 €Ja: 6%
POLYMARKET
POLYMARKET
When will Intellia Therapeutics submit a BLA for Lonvo-z?
0 €before September: 22%KALSHI
KALSHIIn diesen Themen aktiv
Verwandte Nachrichten
NVIDIA Ising Calibration 1.5 Pushes Quantum Computing ForwardBlockchain.News
Crypto is the canary in the coal mine for the quantum computing threat, experts sayCoindesk
Galaxy Digital opens $5M fund for Bitcoin quantum security researchCrypto News
Claude's Fable 5 just solved an 87-year-old math problem, and it matters for bitcoinCoindesk
Google DeepMind, Isomorphic Labs Unveil AI-Powered Bioresilience PlanBlockchain.NewsNVIDIA's Ising Decoder Slashes Color Code Errors 300xBlockchain.NewsRegeln
If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Oct 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Nov 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Dec 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Jan 1, 2027, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.